Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.76 Analyst target: $13.00 Upside: 173.11%
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.